Bile acid metabolism and signaling, the microbiota, and metabolic disease
The diversity, composition, and function of the bacterial community inhabiting the human gastrointestinal tract contributes to host health through its role in producing energy or signaling molecules that regulate metabolic and immunologic functions. Bile acids are potent metabolic and immune signali...
Gespeichert in:
Veröffentlicht in: | Pharmacology & therapeutics (Oxford) 2022-09, Vol.237, p.108238-108238, Article 108238 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 108238 |
---|---|
container_issue | |
container_start_page | 108238 |
container_title | Pharmacology & therapeutics (Oxford) |
container_volume | 237 |
creator | Cai, Jingwei Rimal, Bipin Jiang, Changtao Chiang, John Y.L. Patterson, Andrew D. |
description | The diversity, composition, and function of the bacterial community inhabiting the human gastrointestinal tract contributes to host health through its role in producing energy or signaling molecules that regulate metabolic and immunologic functions. Bile acids are potent metabolic and immune signaling molecules synthesized from cholesterol in the liver and then transported to the intestine where they can undergo metabolism by gut bacteria. The combination of host- and microbiota-derived enzymatic activities contribute to the composition of the bile acid pool and thus there can be great diversity in bile acid composition that depends in part on the differences in the gut bacteria species. Bile acids can profoundly impact host metabolic and immunological functions by activating different bile acid receptors to regulate signaling pathways that control a broad range of complex symbiotic metabolic networks, including glucose, lipid, steroid and xenobiotic metabolism, and modulation of energy homeostasis. Disruption of bile acid signaling due to perturbation of the gut microbiota or dysregulation of the gut microbiota-host interaction is associated with the pathogenesis and progression of metabolic disorders. The metabolic and immunological roles of bile acids in human health have led to novel therapeutic approaches to manipulate the bile acid pool size, composition, and function by targeting one or multiple components of the microbiota-bile acid-bile acid receptor axis. |
doi_str_mv | 10.1016/j.pharmthera.2022.108238 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2685446844</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0163725822001322</els_id><sourcerecordid>2685446844</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-f5825419ce8df1af30fce195174e12448727fe56da548664b75fa07740149aee3</originalsourceid><addsrcrecordid>eNqFkE1PAyEQhonR2Fr9C4ajh24FFhb2aBu_kiZeNPFGWHa2pdmPClsT_73UbfXoaRLmmXmHByFMyYwSmt1uZtu18U2_Bm9mjDAWnxVL1QkaUyXzJDLvp2gcS5pIJtQIXYSwIYRwTtg5GqVC5oyxdIye564GbKwrcQO9KbrahQabtsTBrVpTu3Y1xTEHN876rnBdb6Y_7SNtcekCmACX6KwydYCrQ52gt4f718VTsnx5fF7cLRPLGe-TSigmOM0tqLKipkpJZYHmgkoOlHGuJJMViKw0gqss44UUlSFSckJ5bgDSCboZ9m5997GD0OvGBQt1bVrodkGzTAnOM8V5RNWAxtND8FDprXeN8V-aEr0XqTf6T6Tei9SDyDh6fUjZFQ2Uv4NHcxGYDwDEv3468DpYB62F0nmwvS4793_KN2D8iHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2685446844</pqid></control><display><type>article</type><title>Bile acid metabolism and signaling, the microbiota, and metabolic disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Cai, Jingwei ; Rimal, Bipin ; Jiang, Changtao ; Chiang, John Y.L. ; Patterson, Andrew D.</creator><creatorcontrib>Cai, Jingwei ; Rimal, Bipin ; Jiang, Changtao ; Chiang, John Y.L. ; Patterson, Andrew D.</creatorcontrib><description>The diversity, composition, and function of the bacterial community inhabiting the human gastrointestinal tract contributes to host health through its role in producing energy or signaling molecules that regulate metabolic and immunologic functions. Bile acids are potent metabolic and immune signaling molecules synthesized from cholesterol in the liver and then transported to the intestine where they can undergo metabolism by gut bacteria. The combination of host- and microbiota-derived enzymatic activities contribute to the composition of the bile acid pool and thus there can be great diversity in bile acid composition that depends in part on the differences in the gut bacteria species. Bile acids can profoundly impact host metabolic and immunological functions by activating different bile acid receptors to regulate signaling pathways that control a broad range of complex symbiotic metabolic networks, including glucose, lipid, steroid and xenobiotic metabolism, and modulation of energy homeostasis. Disruption of bile acid signaling due to perturbation of the gut microbiota or dysregulation of the gut microbiota-host interaction is associated with the pathogenesis and progression of metabolic disorders. The metabolic and immunological roles of bile acids in human health have led to novel therapeutic approaches to manipulate the bile acid pool size, composition, and function by targeting one or multiple components of the microbiota-bile acid-bile acid receptor axis.</description><identifier>ISSN: 0163-7258</identifier><identifier>EISSN: 1879-016X</identifier><identifier>DOI: 10.1016/j.pharmthera.2022.108238</identifier><identifier>PMID: 35792223</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Bacteria ; Bile acid ; Bile acid biotransformation ; Bile acid-activated receptor ; Bile Acids and Salts - metabolism ; Gastrointestinal Microbiome - physiology ; Gut microbiota ; Humans ; Lipid Metabolism ; Metabolic disease ; Metabolic Diseases ; Microbiota</subject><ispartof>Pharmacology & therapeutics (Oxford), 2022-09, Vol.237, p.108238-108238, Article 108238</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-f5825419ce8df1af30fce195174e12448727fe56da548664b75fa07740149aee3</citedby><cites>FETCH-LOGICAL-c424t-f5825419ce8df1af30fce195174e12448727fe56da548664b75fa07740149aee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0163725822001322$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35792223$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cai, Jingwei</creatorcontrib><creatorcontrib>Rimal, Bipin</creatorcontrib><creatorcontrib>Jiang, Changtao</creatorcontrib><creatorcontrib>Chiang, John Y.L.</creatorcontrib><creatorcontrib>Patterson, Andrew D.</creatorcontrib><title>Bile acid metabolism and signaling, the microbiota, and metabolic disease</title><title>Pharmacology & therapeutics (Oxford)</title><addtitle>Pharmacol Ther</addtitle><description>The diversity, composition, and function of the bacterial community inhabiting the human gastrointestinal tract contributes to host health through its role in producing energy or signaling molecules that regulate metabolic and immunologic functions. Bile acids are potent metabolic and immune signaling molecules synthesized from cholesterol in the liver and then transported to the intestine where they can undergo metabolism by gut bacteria. The combination of host- and microbiota-derived enzymatic activities contribute to the composition of the bile acid pool and thus there can be great diversity in bile acid composition that depends in part on the differences in the gut bacteria species. Bile acids can profoundly impact host metabolic and immunological functions by activating different bile acid receptors to regulate signaling pathways that control a broad range of complex symbiotic metabolic networks, including glucose, lipid, steroid and xenobiotic metabolism, and modulation of energy homeostasis. Disruption of bile acid signaling due to perturbation of the gut microbiota or dysregulation of the gut microbiota-host interaction is associated with the pathogenesis and progression of metabolic disorders. The metabolic and immunological roles of bile acids in human health have led to novel therapeutic approaches to manipulate the bile acid pool size, composition, and function by targeting one or multiple components of the microbiota-bile acid-bile acid receptor axis.</description><subject>Bacteria</subject><subject>Bile acid</subject><subject>Bile acid biotransformation</subject><subject>Bile acid-activated receptor</subject><subject>Bile Acids and Salts - metabolism</subject><subject>Gastrointestinal Microbiome - physiology</subject><subject>Gut microbiota</subject><subject>Humans</subject><subject>Lipid Metabolism</subject><subject>Metabolic disease</subject><subject>Metabolic Diseases</subject><subject>Microbiota</subject><issn>0163-7258</issn><issn>1879-016X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1PAyEQhonR2Fr9C4ajh24FFhb2aBu_kiZeNPFGWHa2pdmPClsT_73UbfXoaRLmmXmHByFMyYwSmt1uZtu18U2_Bm9mjDAWnxVL1QkaUyXzJDLvp2gcS5pIJtQIXYSwIYRwTtg5GqVC5oyxdIye564GbKwrcQO9KbrahQabtsTBrVpTu3Y1xTEHN876rnBdb6Y_7SNtcekCmACX6KwydYCrQ52gt4f718VTsnx5fF7cLRPLGe-TSigmOM0tqLKipkpJZYHmgkoOlHGuJJMViKw0gqss44UUlSFSckJ5bgDSCboZ9m5997GD0OvGBQt1bVrodkGzTAnOM8V5RNWAxtND8FDprXeN8V-aEr0XqTf6T6Tei9SDyDh6fUjZFQ2Uv4NHcxGYDwDEv3468DpYB62F0nmwvS4793_KN2D8iHg</recordid><startdate>202209</startdate><enddate>202209</enddate><creator>Cai, Jingwei</creator><creator>Rimal, Bipin</creator><creator>Jiang, Changtao</creator><creator>Chiang, John Y.L.</creator><creator>Patterson, Andrew D.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202209</creationdate><title>Bile acid metabolism and signaling, the microbiota, and metabolic disease</title><author>Cai, Jingwei ; Rimal, Bipin ; Jiang, Changtao ; Chiang, John Y.L. ; Patterson, Andrew D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-f5825419ce8df1af30fce195174e12448727fe56da548664b75fa07740149aee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bacteria</topic><topic>Bile acid</topic><topic>Bile acid biotransformation</topic><topic>Bile acid-activated receptor</topic><topic>Bile Acids and Salts - metabolism</topic><topic>Gastrointestinal Microbiome - physiology</topic><topic>Gut microbiota</topic><topic>Humans</topic><topic>Lipid Metabolism</topic><topic>Metabolic disease</topic><topic>Metabolic Diseases</topic><topic>Microbiota</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cai, Jingwei</creatorcontrib><creatorcontrib>Rimal, Bipin</creatorcontrib><creatorcontrib>Jiang, Changtao</creatorcontrib><creatorcontrib>Chiang, John Y.L.</creatorcontrib><creatorcontrib>Patterson, Andrew D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacology & therapeutics (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cai, Jingwei</au><au>Rimal, Bipin</au><au>Jiang, Changtao</au><au>Chiang, John Y.L.</au><au>Patterson, Andrew D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bile acid metabolism and signaling, the microbiota, and metabolic disease</atitle><jtitle>Pharmacology & therapeutics (Oxford)</jtitle><addtitle>Pharmacol Ther</addtitle><date>2022-09</date><risdate>2022</risdate><volume>237</volume><spage>108238</spage><epage>108238</epage><pages>108238-108238</pages><artnum>108238</artnum><issn>0163-7258</issn><eissn>1879-016X</eissn><abstract>The diversity, composition, and function of the bacterial community inhabiting the human gastrointestinal tract contributes to host health through its role in producing energy or signaling molecules that regulate metabolic and immunologic functions. Bile acids are potent metabolic and immune signaling molecules synthesized from cholesterol in the liver and then transported to the intestine where they can undergo metabolism by gut bacteria. The combination of host- and microbiota-derived enzymatic activities contribute to the composition of the bile acid pool and thus there can be great diversity in bile acid composition that depends in part on the differences in the gut bacteria species. Bile acids can profoundly impact host metabolic and immunological functions by activating different bile acid receptors to regulate signaling pathways that control a broad range of complex symbiotic metabolic networks, including glucose, lipid, steroid and xenobiotic metabolism, and modulation of energy homeostasis. Disruption of bile acid signaling due to perturbation of the gut microbiota or dysregulation of the gut microbiota-host interaction is associated with the pathogenesis and progression of metabolic disorders. The metabolic and immunological roles of bile acids in human health have led to novel therapeutic approaches to manipulate the bile acid pool size, composition, and function by targeting one or multiple components of the microbiota-bile acid-bile acid receptor axis.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>35792223</pmid><doi>10.1016/j.pharmthera.2022.108238</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-7258 |
ispartof | Pharmacology & therapeutics (Oxford), 2022-09, Vol.237, p.108238-108238, Article 108238 |
issn | 0163-7258 1879-016X |
language | eng |
recordid | cdi_proquest_miscellaneous_2685446844 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Bacteria Bile acid Bile acid biotransformation Bile acid-activated receptor Bile Acids and Salts - metabolism Gastrointestinal Microbiome - physiology Gut microbiota Humans Lipid Metabolism Metabolic disease Metabolic Diseases Microbiota |
title | Bile acid metabolism and signaling, the microbiota, and metabolic disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T12%3A56%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bile%20acid%20metabolism%20and%20signaling,%20the%20microbiota,%20and%20metabolic%20disease&rft.jtitle=Pharmacology%20&%20therapeutics%20(Oxford)&rft.au=Cai,%20Jingwei&rft.date=2022-09&rft.volume=237&rft.spage=108238&rft.epage=108238&rft.pages=108238-108238&rft.artnum=108238&rft.issn=0163-7258&rft.eissn=1879-016X&rft_id=info:doi/10.1016/j.pharmthera.2022.108238&rft_dat=%3Cproquest_cross%3E2685446844%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2685446844&rft_id=info:pmid/35792223&rft_els_id=S0163725822001322&rfr_iscdi=true |